The importance of early diagnosis and treatment of actinic keratosis - 09/12/12
Abstract |
Chronic, long-term sun exposure results in genetic changes in epidermal keratinocytes and the development of various skin lesions ranging from actinic keratosis (AK) to skin cancer. AK lesions may first appear as rough, scaly spots on sun-exposed skin, and, although most individual AK lesions do not become invasive cancers, the majority of invasive squamous cell carcinomas originate from AK. Genetic analysis demonstrates that ultraviolet radiation–induced mutations and changes in gene expression are present in squamous cell carcinoma, AK, and clinically normal-appearing perilesional sun-exposed skin, which supports the progressive nature of keratinocyte transformation. The presence of certain clinical features, such as large size, ulceration, or bleeding, suggests an increased risk of disease progression. The risk is also increased by evidence of extensive solar damage, advanced age, and immunosuppression. Early diagnosis and consideration for treatment are indicated to clear actinically damaged sites and diminish the risk of invasive squamous cell carcinoma.
Le texte complet de cet article est disponible en PDF.Key words : actinic keratosis, field cancerization, genetic mutations, immunosuppression, p53, risk factors
Abbreviations used : AK, BCC, CI, NMSC, OCT, OR, OTR, RCM, SCC, UV
Plan
Publication of this article was supported by a grant from LEO Pharma Inc., Parsippany, NJ. |
|
Disclosure: Dr Rigel is an advisory board member and consultant for Graceway Pharmaceuticals, PharmaDerm, and LEO Pharma Inc, and a speaker for Graceway Pharmaceuticals and PharmaDerm. Dr Stein Gold is an advisory board member and investigator for Galderma, Stiefel, and LEO Pharma Inc, and a speaker for Galderma and LEO Pharma Inc. |
|
Reprint requests: Panagiotis Zografos, LEO Pharma Inc., 1 Sylvan Way, Parsippany, NJ 07054. E-mail: panagiotis.zografos@leo-pharma.com. |
Vol 68 - N° 1S1
P. S20-S27 - janvier 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?